# Spero Therapeutics, Inc.: Form 8-K, filed Oct 28, 2021

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2021-10-28
- Accepted by EDGAR: Oct 28, 2021, 08:13 ET
- Period: 2021-10-27
- Accession: 0001193125-21-310428
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312521310428/d236805d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312521310428/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312521310428/d236805d8k.htm

Filed Oct 28, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-310428. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
